Afuco™ Anti-Human VEGF ADCC Therapeutic Antibody (APX003), ADCC Enhanced
Anti-VEGF ADCC Enhanced Antibody (APX003) is an ADCC enhanced antibody produced by our Afuco™ platform. APX003 is a humanized monoclonal antibody directed against VEGF, and is intended for the treatment of multiple malignancies.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-632CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | VEGF |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤6 months at 4°C; ≥6 months at -20°C. |